{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:01:56Z","timestamp":1790146916582,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tracli.2017.05.016","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T11:45:36Z","timestamp":1498736736000},"page":"227-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment"],"prefix":"10.1016","volume":"24","author":[{"given":"F.","family":"Pirenne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2017.05.016_bib0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tracli.2017.05.016_bib0135","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1182\/blood.V79.7.1657.1657","article-title":"A modified transfusion program for prevention of stroke in sickle cell","volume":"79","author":"Cohen","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.016_bib0140","article-title":"French guidelines for the management of adult sickle cell disease: 2015 update","volume":"36","author":"Habibi","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.tracli.2017.05.016_bib0145","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0150","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1537-2995.2008.01693.x","article-title":"Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review","volume":"48","author":"Win","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.016_bib0155","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1537-2995.1997.37497265337.x","article-title":"Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients\u2019 red cells","volume":"37","author":"King","year":"1997","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.016_bib0160","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0165","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2013-03-490623","article-title":"High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors","volume":"122","author":"Chou","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.016_bib0170","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.3324\/haematol.2014.104703","article-title":"Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype","volume":"99","author":"Silvy","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2017.05.016_bib0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.tracli.2008.10.002","article-title":"Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply","volume":"15","author":"Meunier","year":"2008","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0180","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ajh.24397","article-title":"Early occurrence of red blood cell alloimmunization in patients with sickle cell disease","volume":"91","author":"Sins","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/bjh.13123","article-title":"Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease","volume":"168","author":"Fasano","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0190","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.016_bib0195","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/eji.201445187","article-title":"Phenotypic differences of CD4+ T cells in response to red blood cell immunization in transfused sickle cell disease patients","volume":"45","author":"Vingert","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0200","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/ajh.23488","article-title":"Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease","volume":"88","author":"Bao","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0205","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/trf.13920","article-title":"Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms","volume":"57","author":"Sippert","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.016_bib0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/vox.12217","article-title":"The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease","volume":"108","author":"Noizat-Pirenne","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2017.05.016_bib0215","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tracli.2011.09.001","article-title":"Relevance of RH variants in transfusion of sickle cell patients","volume":"18","author":"Noizat-Pirenne","year":"2011","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0220","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1537-2995.2009.02102.x","article-title":"D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters","volume":"49","author":"Flegel","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.016_bib0225","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/trf.12987","article-title":"Changing practice: red blood cell typing by molecular methods for patients with sickle cell disease","volume":"55","author":"Casas","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2017.05.016_bib0230","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0235","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2017.05.016_bib0240","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3324\/haematol.2010.038307","article-title":"Delayed hemolytic transfusion reaction in children with sickle cell disease","volume":"96","author":"de Montalembert","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.tracli.2017.05.016_bib0245","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2017.05.016_bib0250","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transci.2015.08.005","article-title":"Successful reduction of plasma free-hemoglobin using therapeutic plasma exchange: a case report","volume":"54","author":"Hayes","year":"2016","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782017300782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:26Z","timestamp":1761129386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782017300782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1246782017300782"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.016","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2017.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}